Results 141 to 150 of about 57,678 (240)

Chitosan‐Based Hydrogels for Periodontal Therapy: From Drug‐Polymer Chemistry to Smart Multifunctional and Regenerative Systems

open access: yesChemistry &Biodiversity, Volume 23, Issue 11, November 2026.
Chitosan‐based hydrogels are evolving from simple local drug carriers into multifunctional periodontal platforms that integrate antimicrobial, anti‐inflammatory, antioxidant, and regenerative functions. Chemical crosslinking, nanocomposite design, and stimulus‐responsive architectures enable adaptive therapeutic delivery.
Vikesh Kumar   +3 more
wiley   +1 more source

Evaluation of periodontal health in patients taking atorvastatin

open access: yesCaspian journal of dental research, 2018
Introduction: Periodontal disease as a chronic inflammatory condition is more prevalent in adults. Considering the anti-inflammatory effect of statins and the need to find out the effects of these drugs on the prevention and treatment of periodontal ...
Kosar Rezaei Talarposhti   +3 more
doaj  

Porównanie intensywnego i standardowego obniżania stężenia lipidów za pomocą atorwastatyny u chorych z dyslipidemią cukrzycową Badanie DALI - podwójnie ślepa, randomizowana próba kliniczna kontrolowana placebo, przeprowadzona u chorych na cukrzycę typu 2 i dyslipidemię cukrzycową [PDF]

open access: yes, 2002
INTRODUCTION. In patients with type 2 diabetes, intensive glucose regulation, although effective for microangiopathy, has not been shown to have unambiguous preventive effects on the occurrence of cardiovascular disease.
Intervention, Diabetes Atorvastatin Lipid
core  

Hemophagocytic Lymphohistiocytosis in a Patient With Alcohol‐Associated Liver Disease: A Case Report Highlighting Diagnostic Challenges

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome with nonspecific clinical manifestations that can mimic common conditions in patients with alcohol dependence. Early clinical suspicion and rapid initiation of treatment are essential to prevent fatal outcomes.
Adalis Rivera   +4 more
wiley   +1 more source

Outcomes and atorvastatin administration characteristics.

open access: yes
Outcomes and atorvastatin administration characteristics.
Rene Rodríguez-Gutiérrez (17720167)   +8 more
core   +1 more source

Acute Angina in Anomalous Left Main Coronary Artery With Prepulmonic Course: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Although a prepulmonic left main coronary artery is usually considered a lower‐risk AAOCA subtype, it may still be associated with acute ischemic symptoms when significant atherosclerotic coronary artery disease is present. Multimodality imaging is essential for defining the coronary anatomy, and coronary artery bypass grafting may be the ...
Mohammad Rouzbahani   +4 more
wiley   +1 more source

PHARMACOKINETIC STUDY OF ATORVASTATIN AFTER SINGLE DOSE ADMINISTRATION AMONG PAKISTANI POPULATION

open access: yesPakistan Armed Forces Medical Journal, 2017
Objective: To obtain pharmacokinetic data of Orvastin, a newly launched formulation of atorvastatin, in healthy males of Pakistan. Study Design: It was quasi-experimental design. Place and Duration of Study: Study was conducted at Centre for Research in
Imrana Maqsood,   +6 more
doaj  

A Rare Case Report of Type II Kounis Syndrome With Literature Review: Acute Anterior ST Elevation Myocardial Infarction Following Bee Sting

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Kounis syndrome (KS), also known as allergic angina, is a rare but serious condition defined by acute coronary syndrome occurring alongside a hypersensitivity reaction. We report the case of a 42‐year‐old male smoker who developed Type II KS after a hymenoptera sting.
Sara Tarkiani   +6 more
wiley   +1 more source

Evaluation of changes in the global longitudinal strain for left ventricular function before and after eight weeks of taking high dose of atorvastatin in patients with coronary slow flow phenomenon

open access: yesBMC Cardiovascular Disorders
Background Coronary Slow Flow Phenomenon (CSFP) is a well-recognized clinical entity characterized by delayed opacification of coronary arteries in the presence of a normal coronary angiogram.
Nakisa Khansari   +4 more
doaj   +1 more source

Atorvastatin blocks Sonic Hedgehog medulloblastoma progression through apoptosis

open access: yes, 2017
Aberrant activation of Sonic Hedgehog signaling transduction leads to formation of numerous malignancies, including medulloblastoma (MB) – the most common malignant pediatric tumor.
Z.I. Abramova, R.E. Gordon
core  

Home - About - Disclaimer - Privacy